None listed
Conditions
Brief summary
The study is to compare the outcome of the two surgical techniques to raise the anterolateral thigh flap. The primary outcome of study is survival and the secondary outcomes are dysesthesia, numbness and paraestehsia.
Interventions
Soft tissue reconstruction which requires free tissue transfer will be selected. Wound will be prepared with debrima or tumor resection and recipient vessels will be prepared by the surgical team. The Suprafacial anterolateral thigh flap will be marked according to the wound size, perforators will be marked with the help of hand held doppler. The flap will be raised supra facial, perforators will be identified and then a cuff of facial will be taken around the perforator. Dissection will be done
Soft tissue reconstruction which requires free tissue transfer will be selected. Wound will be prepared with debrima or tumor resection and recipient vessels will be prepared by the surgical team. The Suprafacial anterolateral thigh flap will be marked according to the wound size, perforators will be marked with the help of hand held doppler. The flap will be raised supra facial, perforators will be identified and then a cuff of facial will be taken around the perforator. Dissection will be done to identify the donor vessels. once the required length of vessels achieved the flap will be divided, insetting and anastomosis will be done by the surgical team with one or two Plastic surgeons leading the team. The flap raising will be done in around 2 hours time. Donor site will be closed primarily or with split skin graft.
Sponsors
Farrukh Aslam Khalid
Study design
Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
15 Years to 45 Years
Healthy volunteers
No
Inclusion criteria
Patients with soft tissue defects due to trauma or cancer ablation which requires a free tissue for reconstruction.
Exclusion criteria
• Patients with history of diabetes mellitus (FBS>110 mg/dl on presentation). • Patients with vascular or penetrating injury • Patients who lost to follow
Outcome results
None listed